Modulation of transcription factors by curcumin

Advances in Experimental Medicine and Biology

Volumn 595, Issue , 2007, Pages 127-148

  Shishodia, Shishir ^a   Singh, Tulika ^a   Chaturvedi, Madan M ^b  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BETA CATENIN; CURCUMIN; CYCLIC AMP; EARLY GROWTH RESPONSE FACTOR 1; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P53; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; VASCULOTROPIN;

APOPTOSIS; CELL CYCLE ARREST; CELL DIFFERENTIATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; LUNG TOXICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

CURCUMA LONGA;

EID: 84934444448     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-46401-5_4     Document Type: Review

References (100)

1. B. B. Aggarwal and S. Shishodia, Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397-1421 (2006).
2. S. Shishodia, G. Sethi, and B. B. Aggarwal, Curcumin: getting back to the roots. Ann NY Acad Sci 1056, 206-217 (2005).
3. B. B. Aggarwal, Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203-208 (2004).
4. S. Shishodia and B. B. Aggarwal, Nuclear factor-kappaB: A friend or a foe in cancer? Biochem Pharmacol 68, 1071-1080 (2004).
5. A. S. Baldwin, Jr., Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107, 3-6 (2001).
6. H. L. Pahl, Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866 (1999).
7. D. K. Giri and B. B. Aggarwal, Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem 273, 14,008-14,014 (1998).
8. H. Lee, M. Wu, F. A. La Rosa, M. P. Duyao, A J. Buckler, and G. E. Sonenshein, Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells. Curr Top Microbiol Immunol 194, 247-255 (1995).
9. C. Y. Wang, M. W. Mayo, and A. S.Baldwin, Jr. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274, 784-787 (1996).
10. A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053-1062 (2003).
11. R. J. Anto, Mukhopadhyay, K. Denning, and B. B. Aggarwal, Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23, 143-150 (2002).
12. N. Mori, M. Fujii, S. Ikeda, Y. Yamada, M. Tomonaga, D. W. Ballard, and N. Yamamoto, Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 93, 2360-2368 (1999).
13. C. E. Bueso-Ramos, F. C. Rocha, S. Shishodia, L. J. Medeiros, H. M. Kantarjian, S. Vadhan-Raj, Z. Estrov, T. L. Smith, M. H. Nguyen, and B. B. Aggarwal, Expression of constitutively active nuclear factor-kappa B RelA transcription factor in blasts of acute myeloid leukemia. Hum Pathol 35, 246-253 (2004).
14. T. Dorai, Y. C. Cao, B. Dorai, R. Buttyan, and A. E. Katz, Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47, 293-303 (2001).
15. H. Nakshatri, P. Bhat-Nakshatri, D. A. Martin, DR. J. Goulet, Jr., and G. W. Sledge, Jr., Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17, 3629-3639 (1997).
16. Z. Wang, Y. Zhang, S. Banerjee, Y. Li, and F. H. Sarkar, Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106, 2503-2513 (2006).
17. S. Singh and B. B. Aggarwal, Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 270, 24,995-25,000 (1995).
18. S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69, 195-206 (2006).
19. C. Jobin, C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D. A. Brenner, and R. B. Sartor, Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163, 3474-3483 (1999).
20. S. M. Plummer, K. A. Holloway, M. M. Manson, R. J. Munks, A. Kaptein, S. Farrow, and L. Howells, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18, 6013-6020 (1999).
21. R. K. Thomas, M. L. Sos, T. Zander, O. Mani, A. Popov, D. Berenbrinker, S. Smola-Hess, J. L. Schultze, and J. Wolf, Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. Clin Cancer Res 11, 8186-8194 (2005).
22. S. Shishodia, P. Potdar, C. G. Gairola, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: Correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24, 1269-1279 (2003).
23. S. Shishodia, H. M. Amin, R. Lai, and B. B. Aggarwal, Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70, 700-713 (2005).
24. S. Philip and G. C. Kundu, Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 278, 14,487-14,497 (2003).
25. M. Zheng, S. Ekmekcioglu, E. T. Walch, C. H. Tang, and E. R. Grimm, Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res 14, 165-171 (2004).
26. K. H. Kim, H. Y. Park, J. H. Nam, J. E. Park, J. Y Kim, M. I. Park, K. O. Chung, K. Y. Park, and J. Y. Koo, The inhibitory effect of curcumin on the growth of human colon cancer cells (HT-29, WiDr) in vitro. Korean J Gastroenterol 45, 277-284 (2005).
27. B. B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R. A. Newman, C. E. Bueso-Ramos, and J. E. Price, Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490-7498 (2005).
28. R. Eferl and E. F. Wagner, AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 3, 859-868 (2003).
29. M. Takakura, S. Kyo, M. Inoue, W. E. Wright, and J. W. Shay, Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol Cell Biol 25, 8037-8043 (2005).
30. T. Bowman, M. A. Broome, D. Sinibaldi, W. Wharton, W. J. Pledger, J. M. Sedivy, R. Irby, T. Yeatman, S. A. Courtneidge, and R. Jove, Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci USA 98, 7319-7324 (2001).
31. J. F. Bromberg, C. M. Horvath, D. Besser, W.W. Lathem, and J. E. Darnell, Jr., Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18, 2553-2558 (1998).
32. F. C. Hsieh, G. Cheng, and J. Lin, Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem Biophys Res Commun 335, 292-299 (2005).
33. J. Coyle-Rink, L. Del Valle, T. Sweet, K. Khalili, and S. Amini, Developmental expression of Wnt signaling factors in mouse brain. Cancer Biol Ther 1, 640-645 (2002).
34. Y. Kim, R. C. Sills, and C. D. Houle, Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Toxicol Pathol 33, 175-180 (2005).
35. Y. Zhai, R. Wu, D. R. Schwartz, D. Darrah, H. Reed, F. T. Kolligs, M. T. Nieman, E. R. Fearon, and K. K. Cho, Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas. Am J Pathol 160, 1229-1238 (2002).
36. M. M. Montano, A. K. Jaiswal, and B. S. Katzenellenbogen, Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta. J Biol Chem 273, 25,443-25,449 (1998).
37. M. Zhu and W. E. Fahl, Functional characterization of transcription regulators that interact with the electrophile response element. Biochem Biophys Res Commun 289, 212-219 (2001).
38. A. Chen, J. Xu, and A. C. Johnson, Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25, 278-287 (2006).
39. M. Fu, X. Zhu, J. Zhang, J. Liang, Y. Lin, L. Zhao, M. U. Ehrengruber, and Y. E. Chen, Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene 315, 33-41 (2003).
40. Y. Moon, F. G. Bottone, Jr., M. F. McEntee, and T. E. Eling, Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Mol Cancer Ther 4, 1551-1558 (2005).
41. L. Stefano, J. Al Sarraj, O. G. Rossler, C. Vinson, and G. Thiel, Up-regulation of tyrosine hydroxylase gene transcription by tetradecanoylphorbol acetate is mediated by the transcription factors Ets-like protein-1 (Elk-1) and Egr-1. J Neurochem 97, 92-104 (2006).
42. D. Xiao, D. Chinnappan, R. Pestell, C. Albanese, and H. C. Weber, Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells. Cancer Res 65, 9934-9942 (2005).
43. J. Svaren, T. Ehrig, S. A. Abdulkadir, M. U. Ehrengruber, M. A. Watson, and J. Milbrandt, EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem 275, 38,524-38,531 (2000).
44. J. Li, M. Tan, L. Li, D. Pamarthy, T. S. Lawrence, and Y. Sun, SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing. Neoplasia 7, 312-323 (2005).
45. Y. Sun, p53 and its downstream proteins as molecular targets of cancer. Mol Carcinog 45, 409-415 (2006).
46. A. C. Wild, H. R. Moinova, and R. T. Mulcahy, Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 274, 33,627-33,636 (1999).
47. J. Kim and G. A. Coetzee, Prostate specific antigen gene regulation by androgen receptor. J Cell Biochem 93, 233-241 (2004).
48. P. Petrusz, D. A. Jeyaraj, and G. Grossman, Microarray analysis of androgen-regulated gene expression in testis: the use of the androgen-binding protein (ABP)-transgenic mouse as a model. Reprod Biol Endocrinol 3, 70 (2005).
49. I. Bogacka, H. Xie, G. A. Bray, and S. R. Smith, The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care 27, 1660-1667 (2004).
50. P. Delerive, F. Martin-Nizard, G. Chinetti, F. Trottein, J. C. Fruchart, J. Najib, P. Duriez, and B. Staels, Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 85, 394-402 (1999).
51. S. Hummasti and P. Tontonoz, The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis. Mol Endocrinol 20, 1261-1275 (2006).
52. P. Dikshit, A. Goswami, A. Mishra, M. Chatterjee, and N. R. Jana, Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function. Neurotox Res 9, 29-37 (2006).
53. C. H. Yeh, Y. M. Lin, Y. C. Wu, and P. J. Lin, Inhibition of NF-kappa B activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. J Cardiovasc Pharmacol 45, 301-309 (2005).
54. S. Wessler, P. Muenzner, T. F. Meyer, and M. Naumann, The anti-inflammatory compound curcumin inhibits Neisseria gonorrhoeae-induced NF-kappaB signaling, release of pro-inflammatory cytokines/chemokines and attenuates adhesion in late infection. Biol Chem 386, 481-490 (2005).
55. M. Karin, Z. Liu, and E. Zandi, AP-1 function and regulation. Curr Opin Cell Biol 9, 240-246 (1997).
56. Y. Xia, C. Makris, B. Su, E. Li, J. Yang, G. R. Nemerow, and M. Karin, MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc Natl Acad Sci USA 97, 5243-5248 (2000).
57. C. Huang, J. Li, W. Y. Ma, and Z. Dong, JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem 274, 29,672-29,676 (1999).
58. M. T. Huang, T. Lysz, T. Ferraro, T. F. Abidi, J. D. Laskin, and A. H. Conney, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51, 813-819 (1991).
59. Y. R. Chen and T. H. Tan, Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17, 173-178 (1998).
60. A. Bierhaus, Y. Zhang, P. Quehenberger, T. Luther, M. Haase, M. Muller, N. Mackman, R. Ziegler, and P. P. Nawroth, The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost 77, 772-782 (1997).
61. D. A. Dickinson, K. E. Iles, H. Zhang, V. Blank, and H. J. Forman, Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB J 17, 473-475 (2003).
62. M. Tomita, H. Kawakami, J. N. Uchihara, T. Okudaira, M. Masuda, N. Takasu, T. Matsuda, T. Ohta, Y. Tanaka, and N. Mori, Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. Leuk Res 30, 313-321 (2006).
63. C. S. Divya and M. R. Pillai, Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 45, 320-332 (2006).
64. C. Polytarchou, M. Hatziapostolou, and E. Papadimitriou, Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J Biol Chem 280, 40,428-40,435 (2005).
65. B. K. Prusty and B. C. Das, Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 113, 951-960 (2005).
66. M. S. Squires, E. A. Hudson, L. Howells, S; Sale, C. E. Houghton, J. L. Jones, L. H. Fox, M. Dickens, S. A. Prigent, and M. M. Manson, Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/ protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol 65, 361-376 (2003).
67. M. L. Cho, Y. O. Jung, Y. M. Moon, S. Y. Min, C. H. Yoon, S. H. Lee, S. H. Park, C. S. Cho, D. M. Jue, and H. Y. Kim, Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett 103, 159-166 (2006).
68. U. R. Pendurthi and L. V. Rao, Suppression of transcription factor Egr-1 by curcumin. Thromb Res 97, 179-189 (2000).
69. J. E. Darnell, Jr., I. M. Kerr, and G. R. Stark, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (1994).
70. J. E. Darnell, Jr., STATs and gene regulation. Science 277, 1630-1635 (1997).
71. C. L. Yu, D. J. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz, and R. Jove, Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81-83 (1995).
72. J. R. Grandis, S. D. Drenning, A. Chakraborty, M. Y. Zhou, Q. Zeng, A.S. Pitt, and D. J. Tweardy, Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. J Clin Invest 102, 1385-1392 (1998).
73. N. Carlesso, D. A. Frank, and J. D. Griffin, Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183, 811-820 (1996).
74. R. M. Weber-Nordt, C. Egen, J. Wehinger, W. Ludwig, V. Gouilleux-Gruart, R. Mertelsmann, and J. Finke, Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88, 809-816 (1996).
75. A. C. Bharti, N. Donato, and B. B. Aggarwal, Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171, 3863-3871 (2003).
76. H. Y. Kim, E. J. Park, E. H. Joe, and I. Jou, Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol 171, 6072-6079 (2003).
77. W. Q. Li, F. Dehnade, and M. Zafarullah, Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 166, 3491-3498 (2001).
78. C. Natarajan and J. J. Bright, Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168, 6506-6513 (2002).
79. W. H. Chen, Y. Chen, G. H. Cui, J. X. Gu, D. Hu, W. K. Chen, and X. G. Li, Effect of curcumin on STAT5 signaling pathway in primary CML cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 12, 572-576 (2004).
80. W. H. Chen, Y. Chen, J. X. Gu, and J. He, Effect of curcumin on STAT5 signaling molecule in K562 cells. Zhonghua Xue Ye Xue Za Zhi 25, 151-153 (2004).
81. J. Xu, Y. Fu, and A. Chen, Activation of peroxisome proliferator- activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 285, G20-G30 (2003).
82. A. Chen and J. Xu, Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am J Physiol Gastrointest Liver Physiol 288, G447-G456 (2005).
83. S. Zheng and A. Chen, Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 290, G883-G893 (2006).
84. A. M. Siddiqui, X. Cui, R. Wu, W. Dong, M. Zhou, M. Hu, H. H. Simms and P. Wang, The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med 34, 1874-1882 (2006).
85. W. S. el-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
86. B. Vogelstein and K. W.Kinzler, p53 function and dysfunction. Cell 70, 523-526 (1992).
87. S. S. Han, S. T. Chung, D. A. Robertson, D. Ranjan, and S. Bondada, Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93, 152-161 (1999).
88. J. A. Bush, K. J. Cheung, Jr., and G Li, Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271, 305-314 (2001).
89. T. Choudhuri, S. Pal, M. L. Agwarwal, T. Das, and G. Sa, Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512, 334-340 (2002).
90. T. Choudhuri, S. Pal, T. Das, and G. Sa, Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280, 20,059-20,068 (2005).
91. M. J. Park, E. H. Kim, I. C. Park, H. C. Lee, S. H. Woo, J. Y. Lee, Y. J. Hong, C. H. Rhee, S. H. Choi, B. S. Shim, et al., Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. Int J Oncol 21, 379-383 (2002).
92. A. Liontas and H. Yeger, Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24, 987-998 (2004).
93. A. S. Jaiswal, B. P. Marlow, N. Gupta, and S. Narayan, Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21, 8414-8427 (2002).
94. N. N. Mahmoud, A. M. Carothers, D. Grunberger, R. T. Bilinski, M. R. Churchill, C. Martucci, H. L. Newmark, and M. M. Bertagnolli, Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21, 921-927 (2000).
95. E. Balogun, M. Hoque, P. Gong, E. Killeen, C. J. Green, R. Foresti, J. Alam, and R. Motterlini, Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371, 887-895 (2003).
96. S. A. Rushworth, R. M. Ogborne, C. A. Charalambos, and M. A. O'Connell, Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. Biochem Biophys Res Commun 341, 1007-1016 (2006).
97. A. Banning, S. Deubel, D. Kluth, Z. Zhou, and R. Brigelius-Flohe, The GI-GPx gene is a target for Nrf2. Mol Cell Biol 25, 4914-4923 (2005).
98. K. Nakamura, Y. Yasunaga, T. Segawa, D. Ko, J. W. Moul, S. Srivastava, and J. S. Rhim, Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol 21, 825-830 (2002).
99. M. G. Marcu, Y. J. Jung, S. Lee, E. J. Chung, M. J.Lee, J. Trepel, and L. Neckers, Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem 2, 169-174 (2006).
100. K. Balasubramanyam, R. A. Varier, M. Altaf, V. Swaminathan, N. B. Siddappa, U. Ranga, and T. K. Kundu, Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279, 51,163-51,171 (2004).